2.0(top 20%)
impact factor
2.7K(top 10%)
papers
116.6K(top 5%)
citations
111(top 5%)
h-index
2.3(top 20%)
impact factor
4.4K
all documents
121.3K
doc citations
322(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Meta-analysis in clinical trialsContemporary Clinical Trials198633,020
2Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Contemporary Clinical Trials199616,054
3Measurement of health statusContemporary Clinical Trials19893,981
4Optimal two-stage designs for phase II clinical trialsContemporary Clinical Trials19893,264
5Design of the Women’s Health Initiative Clinical Trial and Observational StudyContemporary Clinical Trials19982,421
6A note on quantifying follow-up in studies of failure timeContemporary Clinical Trials19962,072
7Power and sample size calculationsContemporary Clinical Trials19901,779
8A method for assessing the quality of a randomized control trialContemporary Clinical Trials19811,235
9Reproducibility and responsiveness of health status measures statistics and strategies for evaluationContemporary Clinical Trials19911,166
10Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklistsContemporary Clinical Trials19951,089
11Sequenced treatment alternatives to relieve depression (STAR*D): rationale and designContemporary Clinical Trials2004898
12Introduction to sample size determination and power analysis for clinical trialsContemporary Clinical Trials1981897
13Power and Sample Size Calculations for Studies Involving Linear RegressionContemporary Clinical Trials1998863
14Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trialContemporary Clinical Trials2000854
15“Proving the null hypothesis” in clinical trialsContemporary Clinical Trials1982828
16Patient compliance with paper and electronic diariesContemporary Clinical Trials2003773
17Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetesContemporary Clinical Trials2003698
18Do Certain Countries Produce Only Positive Results? A Systematic Review of Controlled TrialsContemporary Clinical Trials1998613
19Publication bias and clinical trialsContemporary Clinical Trials1987589
20Assessing the Quality of Randomized TrialsContemporary Clinical Trials1999556
21Statistical Considerations in the Intent-to-Treat PrincipleContemporary Clinical Trials2000543
22The method of minimization for allocation to clinical trialsContemporary Clinical Trials2002539
23The Age-Related Eye Disease Study (AREDS)Contemporary Clinical Trials1999500
24The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and statusContemporary Clinical Trials2000443
25Assessment of blinding in clinical trialsContemporary Clinical Trials2004398
26Analysis of data from multiclinic trialsContemporary Clinical Trials1986394
27Considerations in the Evaluation of Surrogate Endpoints in Clinical TrialsContemporary Clinical Trials2001381
28Recruitment for controlled clinical trials: Literature summary and annotated bibliographyContemporary Clinical Trials1997364
29Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysisContemporary Clinical Trials1997359
30The Childhood Asthma Management Program (CAMP)Contemporary Clinical Trials1999348
31A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General PopulationContemporary Clinical Trials1998332
32ActiveContemporary Clinical Trials2001328
33Designs for group sequential testsContemporary Clinical Trials1984327
34PS power and sample size program available for free on the internetContemporary Clinical Trials1997299
35Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritisContemporary Clinical Trials1989295
36The Women’s Health Initiative Memory Study (WHIMS)Contemporary Clinical Trials1998287
37Properties of the urn randomization in clinical trialsContemporary Clinical Trials1988277
38Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993 — The perspective of NIH clinical trialistsContemporary Clinical Trials1995276
39Sample-Size Calculations for the Cox Proportional Hazards Regression Model with Nonbinary CovariatesContemporary Clinical Trials2000265
40Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labelsContemporary Clinical Trials2004261
41Monitoring clinical trials: Conditional or predictive power?Contemporary Clinical Trials1986257
42Properties of permuted-block randomization in clinical trialsContemporary Clinical Trials1988256
43A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival:Contemporary Clinical Trials2002249
44SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youthContemporary Clinical Trials2004245
45The bivariate continual reassessment methodContemporary Clinical Trials2002242
46Randomization in clinical trials: Conclusions and recommendationsContemporary Clinical Trials1988236
47Recruitment experience in clinical trials: Literature summary and annotated bibliographyContemporary Clinical Trials1987234
48Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) studyContemporary Clinical Trials1987231
49Stroke Prevention Trial in Sickle Cell AnemiaContemporary Clinical Trials1998228
50An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trialsContemporary Clinical Trials1990227